BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38914686)

  • 1. Mild phenotypes in patients with different deletions in the 3' enhancer region of SHOX.
    Miranda V; Sabeh P; Seiltgens C; Molidperee S; Janelle C; Lemyre E; Campeau PM
    Eur J Hum Genet; 2024 Jun; ():. PubMed ID: 38914686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis.
    Benito-Sanz S; Thomas NS; Huber C; Gorbenko del Blanco D; Aza-Carmona M; Crolla JA; Maloney V; Rappold G; Argente J; Campos-Barros A; Cormier-Daire V; Heath KE
    Am J Hum Genet; 2005 Oct; 77(4):533-44. PubMed ID: 16175500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygous deletions in pseudoautosomal region 1 in an infant with mild manifestations of langer mesomelic dysplasia.
    Tsuchiya T; Shibata M; Numabe H; Jinno T; Nakabayashi K; Nishimura G; Nagai T; Ogata T; Fukami M
    Am J Med Genet A; 2014 Feb; 164A(2):505-10. PubMed ID: 24311385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mosaic compound heterozygosity of SHOX resulting in Leri-Weill dyschondrosteosis with marked short stature: implications for disease mechanisms and recurrence risks.
    Reish O; Huber C; Altarescu G; Chapman-Shimshoni D; Levy-Lahad E; Renbaum P; Mashevich M; Munnich A; Cormier-Daire V
    Am J Med Genet A; 2010 Sep; 152A(9):2230-5. PubMed ID: 20683993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the first de novo PAR1 deletion downstream of SHOX in an individual diagnosed with Léri-Weill dyschondrosteosis (LWD).
    Barroso E; Benito-Sanz S; Belinchón A; Yuste-Checa P; Gracia R; Aragones A; Campos-Barros A; Heath KE
    Eur J Med Genet; 2010; 53(4):204-7. PubMed ID: 20412871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic screening identifies a wide range of mutations involving the SHOX gene, including a common 47.5 kb deletion 160 kb downstream with a variable phenotypic effect.
    Bunyan DJ; Baker KR; Harvey JF; Thomas NS
    Am J Med Genet A; 2013 Jun; 161A(6):1329-38. PubMed ID: 23636926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duplications upstream and downstream of SHOX identified as novel causes of Leri-Weill dyschondrosteosis or idiopathic short stature.
    Bunyan DJ; Baffico M; Capone L; Vannelli S; Iughetti L; Schmitt S; Taylor EJ; Herridge AA; Shears D; Forabosco A; Coviello DA
    Am J Med Genet A; 2016 Apr; 170A(4):949-57. PubMed ID: 26698168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of phenotypic anomalies in four families with deletion of the SHOX enhancer region.
    Gatta V; Palka C; Chiavaroli V; Franchi S; Cannataro G; Savastano M; Cotroneo AR; Chiarelli F; Mohn A; Stuppia L
    BMC Med Genet; 2014 Jul; 15():87. PubMed ID: 25056248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes Associated with SHOX Deficiency.
    Ross JL; Scott C; Marttila P; Kowal K; Nass A; Papenhausen P; Abboudi J; Osterman L; Kushner H; Carter P; Ezaki M; Elder F; Wei F; Chen H; Zinn AR
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5674-80. PubMed ID: 11739418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-occurrence of genomic imbalances on Xp22.1 in the SHOX region and 15q25.2 in a girl with short stature, precocious puberty, urogenital malformations and bone anomalies.
    Monzani A; Babu D; Mellone S; Genoni G; Fanelli A; Prodam F; Bellone S; Giordano M
    BMC Med Genomics; 2019 Jan; 12(1):5. PubMed ID: 30626445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR1 deletions downstream of SHOX are the most frequent defect in a Spanish cohort of Léri-Weill dyschondrosteosis (LWD) probands.
    Benito-Sanz S; del Blanco DG; Aza-Carmona M; Magano LF; Lapunzina P; Argente J; Campos-Barros A; Heath KE
    Hum Mutat; 2006 Oct; 27(10):1062. PubMed ID: 16941489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of variants in non-coding regions of SHOX - Current knowledge.
    Spurna Z; Capkova P; Srovnal J; Duchoslavova J; Punova L; Aleksijevic D; Vrtel R
    Gene; 2022 Apr; 818():146238. PubMed ID: 35074420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.
    Benito-Sanz S; Aza-Carmona M; Rodríguez-Estevez A; Rica-Etxebarria I; Gracia R; Campos-Barros A; Heath KE
    Eur J Hum Genet; 2012 Jan; 20(1):125-7. PubMed ID: 22071895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RARE DOSAGE ABNORMALITIES - COPY NUMBER VARIATIONS FLANKING THE SHOX GENE.
    Gherlan I; Braha E; Manole DC; Radomir L; Nedelcu I; Popa O; Schipor S
    Acta Endocrinol (Buchar); 2023; 19(1):115-124. PubMed ID: 37601716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene.
    Choi WB; Seo SH; Yoo WH; Kim SY; Kwak MJ
    Ann Pediatr Endocrinol Metab; 2015 Sep; 20(3):162-5. PubMed ID: 26512353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SHOX region and its mutations.
    Capone L; Iughetti L; Sabatini S; Bacciaglia A; Forabosco A
    J Endocrinol Invest; 2010 Jun; 33(6 Suppl):11-4. PubMed ID: 21057179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the first recurrent PAR1 deletion in Léri-Weill dyschondrosteosis and idiopathic short stature reveals the presence of a novel SHOX enhancer.
    Benito-Sanz S; Royo JL; Barroso E; Paumard-Hernández B; Barreda-Bonis AC; Liu P; Gracía R; Lupski JR; Campos-Barros Á; Gómez-Skarmeta JL; Heath KE
    J Med Genet; 2012 Jul; 49(7):442-50. PubMed ID: 22791839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygosity for a novel deletion downstream of the SHOX gene provides evidence for an additional long range regulatory region with a mild phenotypic effect.
    Bunyan DJ; Taylor EJ; Maloney VK; Blyth M
    Am J Med Genet A; 2014 Nov; 164A(11):2764-8. PubMed ID: 25125269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdeletion in the SHOX 3' region associated with skeletal phenotypes of Langer mesomelic dysplasia in a 45,X/46,X,r(X) infant and Leri-Weill dyschondrosteosis in her 46,XX mother: implication for the SHOX enhancer.
    Fukami M; Okuyama T; Yamamori S; Nishimura G; Ogata T
    Am J Med Genet A; 2005 Aug; 137(1):72-6. PubMed ID: 16007631
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.